
Oncology NEWS International
- Oncology NEWS International Vol 5 No 4
- Volume 5
- Issue 4
Lower Breast Cancer Mortality Seen With Estrogen Use
SAN FRANCISCO--Use of estrogen supplements may lower breast cancer mortality, an American Cancer Society study has shown. The study, which was discussed at the ACS's science writers meeting, followed 400,000 women who provided data about their cancer risk factors. After 9 years, breast cancer mortality was 16% lower in those women who used estrogen, suggesting that their tumors were less aggressive.
SAN FRANCISCO--Use of estrogen supplements may lower breast cancermortality, an American Cancer Society study has shown. The study,which was discussed at the ACS's science writers meeting, followed400,000 women who provided data about their cancer risk factors.After 9 years, breast cancer mortality was 16% lower in thosewomen who used estrogen, suggesting that their tumors were lessaggressive.
Articles in this issue
about 30 years ago
Antiangiogenesis Agents in Clinical Trials Worldwideabout 30 years ago
Breast Cancer Stamp Debuts in Juneabout 30 years ago
NCI, Department of Defense Sign Clinical Trials Agreementabout 30 years ago
NCI to Fund More Extramural Investigationsabout 30 years ago
Lymphoma, Leukemia Patients Sought for Trial of MoAbabout 30 years ago
'Integrated Symposia' New Feature at ASCO Conferenceabout 30 years ago
Obstacles That Slow Guidelines ImplementationNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Related Content


122 Adjuvant Ribociclib (RIB) Plus Nonsteroidal Aromatase Inhibitor (NSAI) in Patients With HR+/HER2− Early Breast Cancer (EBC): NATALEE 5-Year Outcomes




















































